Scientists
have moved a step closer to an "obesity drug" that may block the
effects of diets high in sugar and fats. In a new research report
published in the December 2013 issue of The FASEB Journal, scientists
show that there is an abnormal amount of an inflammatory protein called
PAR2 in the abdominal fat tissue of overweight and obese humans and
rats. This protein is also increased on the surfaces of human immune
cells by common fatty acids in the diet.
No comments:
Post a Comment